Last reviewed · How we verify

NCT03978650

Risk Factors for Falls and Fall-related Injuries Associated With Mild Neurocognitive Disorders

Status unknown Last updated 23 February 2024
What this trial tests

trial testing Observational in Old Age in 12,000 participants. Status unknown.

Timeline
23 July 2019
Primary endpoint
1 August 2025
1 January 2026

Quick facts

Lead sponsorJewish General Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment12,000
Start date23 July 2019
Primary completion1 August 2025
Estimated completion1 January 2026
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Jewish General Hospital

Who can join

65 and older, any sex, with Old Age or Fall Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the risk for incident falls and fall-related injuries at the onset of neurocognitive disorders in older adults participating in the Canadian Longitudinal Study

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

Other recruiting trials for Old Age

Currently open trials in the same condition.

Other Jewish General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03978650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing